Trial Profile
Safety and Tolerability of LGD-4033, a Novel Non-Steroidal Oral Selective Androgen Receptor Modulator (SARM), in Healthy Men
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jun 2011
Price :
$35
*
At a glance
- Drugs VK 5211 (Primary)
- Indications Hypogonadism
- Focus Adverse reactions
- 16 Jun 2011 New trial record